SIRT6 inhibits endothelial-to-mesenchymal transition through attenuating the vascular endothelial inflammatory response
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 101 (Pt B) , 108240
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81873520)
- Natural Science Foundation of Shaanxi Province (2019JM-394)
This publication has 28 references indexed in Scilit:
- TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft RemodelingScience Translational Medicine, 2014
- The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-JunNature Medicine, 2012
- Epithelial-to-Mesenchymal and Endothelial-to-Mesenchymal TransitionCirculation, 2012
- SIRT6 protects against pathological damage caused by diet‐induced obesityAging Cell, 2010
- Mammalian Sirtuins: Biological Insights and Disease RelevanceAnnual Review of Pathology: Mechanisms of Disease, 2010
- The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1αCell, 2010
- SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life SpanCell, 2009
- Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategiesNature Medicine, 2002
- Molecular Regulation of Atrioventricular Valvuloseptal MorphogenesisCirculation Research, 1995